SEER, INC. Current Assets
SEER, INC. (SEER) had Current Assets of $166.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $166.10M.
- 2026-03-31: Assets, Current $181.59M.
- 2025-12-31: Assets, Current $201.53M.
- 2025-09-30: Assets, Current $214.36M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $166.10M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $181.59M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $201.53M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $214.36M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $225.64M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $255.27M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $253.32M 10-K · filed 2026-03-02 |
| 2024-09-30 | $264.10M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $299.69M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $324.15M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $330.51M 10-K · filed 2025-03-03 |
| 2023-09-30 | $346.12M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $335.38M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $367.38M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $434.98M 10-K · filed 2024-03-04 |
| 2022-09-30 | $450.47M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $466.76M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $457.46M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $411.70M 10-K · filed 2023-03-06 |
| 2021-09-30 | $514.27M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $525.33M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $536.24M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $433.13M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |